share_log

908 Devices Analyst Ratings

Benzinga Analyst Ratings ·  Feb 7, 2023 05:03
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
02/07/2023 40.42% Stephens & Co. → $14 Initiates Coverage On → Overweight
01/06/2023 100.6% SVB Leerink $25 → $20 Maintains Outperform
11/15/2022 150.75% SVB Leerink $30 → $25 Maintains Outperform
03/08/2022 200.9% SVB Leerink $40 → $30 Maintains Outperform
05/14/2021 551.96% SVB Leerink $70 → $65 Maintains Outperform
01/12/2021 551.96% Stifel → $65 Initiates Coverage On → Buy
01/12/2021 Cowen & Co. Initiates Coverage On → Outperform
01/12/2021 602.11% SVB Leerink → $70 Initiates Coverage On → Outperform

What is the target price for 908 Devices (MASS)?

The latest price target for 908 Devices (NASDAQ: MASS) was reported by Stephens & Co. on February 7, 2023. The analyst firm set a price target for $14.00 expecting MASS to rise to within 12 months (a possible 40.42% upside). 4 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for 908 Devices (MASS)?

The latest analyst rating for 908 Devices (NASDAQ: MASS) was provided by Stephens & Co., and 908 Devices initiated their overweight rating.

When is the next analyst rating going to be posted or updated for 908 Devices (MASS)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of 908 Devices, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for 908 Devices was filed on February 7, 2023 so you should expect the next rating to be made available sometime around February 7, 2024.

Is the Analyst Rating 908 Devices (MASS) correct?

While ratings are subjective and will change, the latest 908 Devices (MASS) rating was a initiated with a price target of $0.00 to $14.00. The current price 908 Devices (MASS) is trading at is $9.97, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment